Alice McDonald

5.6k total citations · 3 hit papers
44 papers, 2.4k citations indexed

About

Alice McDonald is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Alice McDonald has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Hematology. Recurrent topics in Alice McDonald's work include Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (10 papers) and Lymphoma Diagnosis and Treatment (7 papers). Alice McDonald is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (10 papers) and Lymphoma Diagnosis and Treatment (7 papers). Alice McDonald collaborates with scholars based in United States, France and United Kingdom. Alice McDonald's co-authors include Mark D. Fleming, Dean R. Campagna, Robert S. Ohgami, Brendan Antiochos, Eric Lieberman Greer, John J. Sharp, Jing Chen, Jane E. Barker, Yuko Fujiwara and Stephen J. Blakemore and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Alice McDonald

41 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells

2005 563 citations Robert S. Ohgami, Dean R. Campagna et al. Nature Genetics profile →
The Steap proteins are metalloreductases

2006 539 citations Robert S. Ohgami, Dean R. Campagna et al. Blood profile →
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

2018 451 citations Antoîne Italiano, Jean‐Charles Soria et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Alice McDonald

Since Specialization

Citations

This map shows the geographic impact of Alice McDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice McDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice McDonald more than expected).

Fields of papers citing papers by Alice McDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice McDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice McDonald. The network helps show where Alice McDonald may publish in the future.

Co-authorship network of co-authors of Alice McDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Alice McDonald. A scholar is included among the top collaborators of Alice McDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice McDonald. Alice McDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics and Pharmacodynamics of KT‐474, a Novel Selective Interleukin‐1 Receptor–Associated Kinase 4 (IRAK4) Degrader, in Healthy Adults 2025 ·Clinical and Translational Science ·Sagar Agarwal, Alice McDonald, (unknown), Dapeng Chen, J. E. Davis, Haojing Rong, (unknown), Anthony Slavin, Ashwin Gollerkeri, Jared Gollob	4
2	IRAK4 Is Overexpressed in Hidradenitis Suppurativa Skin and Correlates with Inflammatory Biomarkers 2024 ·Journal of Investigative Dermatology ·Alice McDonald, Rahul Karnik, Veronica A. Campbell, (unknown), (unknown), Anthony Slavin, Kirti Sharma, Jared Gollob, Afsáneh Alavi	5
3	P464: PULSE DOSING OF POTENT AND SELECTIVE HETEROBIFUNCTIONAL MDM2 DEGRADER KT-253 DRIVES TUMOR REGRESSION AND DEMONSTRATES DIFFERENTIATED PHARMACOLOGY COMPARED TO P53/MDM2 SMALL MOLECULE INHIBITORS. 2023 ·HemaSphere ·Stefanie S. Schalm, Yogesh K. Chutake, Susanne B. Breitkopf, Michele Mayo, Nancy Dumont, Dapeng Chen, Vaishali Dixit, Rahul Karnik, Alice McDonald, (unknown), William Proctor, (unknown), Kan‐Nian Hu, (unknown), Ashwin Gollerkeri, Kirti Sharma, Joseph D. Growney, Juliet A. Williams	1
4	Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia 2022 ·Blood ·Michele Mayo, Yogesh K. Chutake, Rahul Karnik, Alice McDonald, Patricia S. Cho, (unknown), Dapeng Chen, Vaishali Dixit, William Proctor, Susanne B. Breitkopf, (unknown), Kan‐Nian Hu, Kirti Sharma, (unknown), (unknown), Joseph D. Growney, Juliet A. Williams, Stefanie S. Schalm	9
5	Mechanisms of the Anti-Tumor Activity of STAT3 Degraders in Lymphoma 2020 ·Blood ·Haojing Rong, Kirti Sharma, (unknown), Bin Yang, Scott Rusin, Yatao Shi, Joyoti Dey, Rahul Karnik, Michele Mayo, Karen Yuan, Yogesh K. Chutake, Alice McDonald, (unknown), Nan Ji, Phillip Liu, Henry Li, Duncan Walker, Jared Gollob, Nello Mainolfi, (unknown)	0
6	Ktx-120, a Novel Irakimid Degrader of IRAK4 and IMiD Substrates Shows Preferential Activity and Induces Regressions in MYD88-Mutant DLBCL CDX and PDX Models 2020 ·Blood ·Duncan Walker, Michele Mayo, Christine R. Klaus, Dapeng Chen, (unknown), Kirti Sharma, Scott Rusin, Alice McDonald, Jared Gollob, Nello Mainolfi, (unknown)	4
7	KYM‐001, A FIRST‐IN‐CLASS ORAL IRAK4 PROTEIN DEGRADER, INDUCES TUMOR REGRESSION IN XENOGRAFT MODELS OF MYD88‐MUTANT ABC DLBCL ALONE AND IN COMBINATION WITH BTK INHIBITION 2019 ·Hematological Oncology ·Joseph F. Kelleher, Veronica A. Campbell, (unknown), Jared Gollob, Nan Ji, Hari Kamadurai, Christine R. Klaus, (unknown), Christine Loh, Alice McDonald, H. Rong, Scott Rusin, Kirti Sharma, Dominico Vigil, D H Walker, (unknown), Ke Yuan, (unknown), Nello Mainolfi	4
8	Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study breakdown → 2018 ·The Lancet Oncology ·Antoîne Italiano, Jean‐Charles Soria, Maud Toulmonde, Jean‐Marie Michot, Carlo Lucchesi, Andréa Varga, Jean‐Michel Coindre, Stephen J. Blakemore, Alicia Clawson, Benjamin Suttle, Alice McDonald, Mark Woodruff, Scott Ribich, Eric Hedrick, Heike Keilhack, Blythe Thomson, Takashi Owa, Robert A. Copeland, Peter Ho, Vincent Ribrag	451
9	Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924) 2016 ·Investigational New Drugs ·Kit Man Wong, (unknown), Heather M. Selby, Aik Choon Tan, Todd M. Pitts, Stacey M. Bagby, Anna Spreafico, (unknown), Stephen J. Blakemore, Peter F. Smith, Alice McDonald, Allison Berger, John J. Tentler, Sabine Eckhardt	16
10	Phase 2 multi-center study of tazemetostat (EPZ-6438), an inhibitor of enhancer of zeste-homolog 2 (EZH2), in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL). 2016 ·Journal of Clinical Oncology ·Franck Morschhauser, Gilles Salles, Steven Le Gouill, John Radford, Pam McKay, Guillaume Cartron, (unknown), Maria Roche, Stephen J. Blakemore, Alice McDonald, Natalie M. Warholic, (unknown), Peter Ho, Vincent Ribrag	10
11	Potential biomarkers of bortezomib activity in mantle cell lymphoma from the phase 2 PINNACLE trial 2010 ·Leukemia & lymphoma ·André Goy, Steven H. Bernstein, Alice McDonald, Michael D. Pickard, Hongliang Shi, Mark D. Fleming, Barbara M. Bryant, William L. Trepicchio, Richard I. Fisher, Anthony Boral, George Mulligan	19
12	Environmental, trailer, and gender effects on the percentage of dead and non-ambulatory pigs during transport 2009 ·Veterinary Record ·Mhairi A. Sutherland, Alice McDonald, John J. McGlone	6
13	Effects of variations in the environment, length of journey and type of trailer on the mortality and morbidity of pigs being transported to slaughter 2009 ·Veterinary Record ·Mhairi A. Sutherland, Alice McDonald, John J. McGlone	59
14	Immunohistochemical Analyses for Potential Biomarkers of Bortezomib Activity in Mantle Cell Lymphoma from the PINNACLE Phase 2 Trial. 2007 ·Blood ·André Goy, Steven H. Bernstein, Alice McDonald, Michael D. Pickard, Mark D. Fleming, (unknown), William L. Trepicchio, Richard I. Fisher, Anthony Boral, George Mulligan	5
15	CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes 2006 ·The Journal of Immunology ·Dulce Soler, Tobias R. Chapman, Louis Poisson, Lin Wang, Javier Cote-Sierra, Mark Ryan, Alice McDonald, Sunita Badola, Eric R. Fedyk, Anthony J. Coyle, Martin R. Hodge, Roland Kolbeck	117
16	The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron–sulfur cluster biogenesis 2006 ·Human Molecular Genetics ·Corinne Pondarré, Brendan Antiochos, Dean R. Campagna, Stephen L. Clarke, Eric Lieberman Greer, Kathryn M. Deck, Alice McDonald, (unknown), Amy E. Medlock, Jeffery L. Kutok, Sheila A. Anderson, Richard S. Eisenstein, Mark D. Fleming	174
17	Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells breakdown → 2005 ·Nature Genetics ·Robert S. Ohgami, Dean R. Campagna, Eric Lieberman Greer, Brendan Antiochos, Alice McDonald, Jing Chen, John J. Sharp, Yuko Fujiwara, Jane E. Barker, Mark D. Fleming	563
18	A Mammal-Specific Exon of WT1 Is Not Required for Development or Fertility 2002 ·Molecular and Cellular Biology ·Thomas A. Natoli, Alice McDonald, (unknown), Mary Taglienti, David E. Housman, Jordan A. Kreidberg	47
19	α3β1 integrin regulates epithelial cytoskeletal organization 1999 ·Journal of Cell Science ·Zemin Wang, Jordan M. Symons, Stuart L. Goldstein, Alice McDonald, Jeffrey H. Miner, Jordan A. Kreidberg	95
20	Solving Educational Problems through Partnerships. 1986 ·Phi Delta Kappan ·Alice McDonald	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact